STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling

Owen, 2019, JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression, Cancers, 11, 10.3390/cancers11122002 Au-Yeung, 2018, Transcriptional and chromatin regulation in interferon and innate antiviral gene expression, Cytokine Growth Factor Rev., 44, 11, 10.1016/j.cytogfr.2018.10.003 Wieczorek, 2012, Acetylation modulates the STAT signaling code, Cytokine Growth Factor Rev., 23, 293, 10.1016/j.cytogfr.2012.06.005 Sehgal, 2008, Paradigm shifts in the cell biology of STAT signaling, Semin. Cell Dev. Biol., 19, 329, 10.1016/j.semcdb.2008.07.003 Chen, 1998, Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA, Cell, 93, 827, 10.1016/S0092-8674(00)81443-9 Krämer, 2010, Phosphorylation-acetylation switch in the regulation of STAT1 signaling, Mol. Cell. Endocrinol., 315, 40, 10.1016/j.mce.2009.10.007 Chen, 2003, A reinterpretation of the dimerization interface of the N-terminal domains of STATs, Protein Sci., 12, 361, 10.1110/ps.0218903 Mertens, 2006, Dephosphorylation of phosphotyrosine on STAT1 dimers requires extensive spatial reorientation of the monomers facilitated by the N-terminal domain, Genes Dev., 20, 3372, 10.1101/gad.1485406 Staab, 2013, Clinically relevant dimer interface mutants of STAT1 transcription factor exhibit differential gene expression, PLoS ONE, 8, 10.1371/journal.pone.0069903 Meyer, 2004, A single residue modulates tyrosine dephosphorylation, oligomerization, and nuclear accumulation of stat transcription factors, J. Biol. Chem., 279, 18998, 10.1074/jbc.M400766200 Zhong, 2005, Implications of an antiparallel dimeric structure of nonphosphorylated STAT1 for the activation-inactivation cycle, Proc. Natl. Acad. Sci. U S A, 102, 3966, 10.1073/pnas.0501063102 Ho, 2016, STAT2 Is a Pervasive Cytokine Regulator due to Its Inhibition of STAT1 in Multiple Signaling Pathways, PLoS Biol., 14, 10.1371/journal.pbio.2000117 Vinkemeier, 1996, DNA binding of in vitro activated Stat1 alpha, Stat1 beta and truncated Stat1: interaction between NH2-terminal domains stabilizes binding of two dimers to tandem DNA sites, EMBO J., 15, 5616, 10.1002/j.1460-2075.1996.tb00946.x Mao, 2005, Structural bases of unphosphorylated STAT1 association and receptor binding, Mol. Cell, 17, 761, 10.1016/j.molcel.2005.02.021 Braunstein, 2003, STATs dimerize in the absence of phosphorylation, J. Biol. Chem., 278, 34133, 10.1074/jbc.M304531200 Ndubuisi, 1999, Cellular physiology of STAT3: Where's the cytoplasmic monomer?, J. Biol. Chem., 274, 25499, 10.1074/jbc.274.36.25499 Liu, 2005, STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3, Proc. Natl. Acad. Sci. U S A, 102, 8150, 10.1073/pnas.0501643102 Krämer, 2009, A phosphorylation-acetylation switch regulates STAT1 signaling, Genes Dev., 23, 223, 10.1101/gad.479209 Begitt, 2014, STAT1-cooperative DNA binding distinguishes type 1 from type 2 interferon signaling, Nat. Immunol., 15, 168, 10.1038/ni.2794 Wang, 2020, A virus-induced conformational switch of STAT1-STAT2 dimers boosts antiviral defenses, Cell Res Liu, 2020, USP12 translocation maintains interferon antiviral efficacy by inhibiting CBP acetyltransferase activity, PLoS Pathog., 16, 10.1371/journal.ppat.1008215 Krämer, 2006, Acetylation of Stat1 modulates NF-kappaB activity, Genes Dev., 20, 473, 10.1101/gad.364306 Ginter, 2012, Histone deacetylase inhibitors block IFNgamma-induced STAT1 phosphorylation, Cell. Signal, 24, 1453, 10.1016/j.cellsig.2012.02.018 Zhang, 2020, The HDAC3 inhibitor RGFP966 ameliorated ischemic brain damage by downregulating the AIM2 inflammasome, FASEB J., 34, 648, 10.1096/fj.201900394RRR Deng, 2018, HDAC is indispensable for IFN-gamma-induced B7–H1 expression in gastric cancer, Clin. Epigenetics, 10, 153, 10.1186/s13148-018-0589-6 Kaowinn, 2017, Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling, Cell. Oncol. (Dordr.), 40, 549, 10.1007/s13402-017-0343-7 Kotla, 2015, Reactive Oxygen Species (ROS) Mediate p300-dependent STAT1 Protein Interaction with Peroxisome Proliferator-activated Receptor (PPAR)-gamma in CD36 Protein Expression and Foam Cell Formation, J. Biol. Chem., 290, 30306, 10.1074/jbc.M115.686865 Kotla, 2017, ROS via BTK-p300-STAT1-PPARgamma signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation, Redox Biol., 11, 350, 10.1016/j.redox.2016.12.005 Park, 2018, Novel identification of STAT1 as a crucial mediator of ETV6-NTRK3-induced tumorigenesis, Oncogene, 37, 2270, 10.1038/s41388-017-0102-2 Noack, 2017, Analysis of the interplay between all-trans retinoic acid and histone deacetylase inhibitors in leukemic cells, Arch. Toxicol., 91, 2191, 10.1007/s00204-016-1878-5 Cudejko, 2011, p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages, Blood, 118, 2556, 10.1182/blood-2010-10-313106 Stronach, 2011, HDAC4-regulated STAT1 activation mediates platinum resistance in ovarian cancer, Cancer Res., 71, 4412, 10.1158/0008-5472.CAN-10-4111 Weinert, 2018, Time-Resolved Analysis Reveals Rapid Dynamics and Broad Scope of the CBP/p300 Acetylome, Cell, 174, 231, 10.1016/j.cell.2018.04.033 Hansen, 2019, Analysis of human acetylation stoichiometry defines mechanistic constraints on protein regulation, Nat. Commun., 10, 1055, 10.1038/s41467-019-09024-0 Ginter, 2014, Arginine residues within the DNA binding domain of STAT3 promote intracellular shuttling and phosphorylation of STAT3, Cell. Signal, 26, 1698, 10.1016/j.cellsig.2014.03.033 Mahendrarajah, 2017, HSP90 is necessary for the ACK1-dependent phosphorylation of STAT1 and STAT3, Cell. Signal, 39, 9, 10.1016/j.cellsig.2017.07.014 Krämer, 2008, Histone deacetylase inhibitors and hydroxyurea modulate the cell cycle and cooperatively induce apoptosis, Oncogene, 27, 732, 10.1038/sj.onc.1210677 Göder, 2015, Lipoic acid inhibits the DNA repair protein O 6-methylguanine-DNA methyltransferase (MGMT) and triggers its depletion in colorectal cancer cells with concomitant autophagy induction, Carcinogenesis, 36, 817, 10.1093/carcin/bgv070 Nyman, 2000, Proteome analysis reveals ubiquitin-conjugating enzymes to be a new family of interferon-alpha-regulated genes, Eur. J. Biochem., 267, 4011, 10.1046/j.1432-1327.2000.01433.x Chang, 1991, Molecular and functional analysis of the virus- and interferon-inducible human MxA promoter, Arch. Virol., 117, 1, 10.1007/BF01310488 Brierley, 2006, Identification of GAS-dependent interferon-sensitive target genes whose transcription is STAT2-dependent but ISGF3-independent, FEBS J., 273, 1569, 10.1111/j.1742-4658.2006.05176.x Blaszczyk, 2015, STAT2/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1, Biochem J., 466, 511, 10.1042/BJ20140644 Leung, 1995, Role of STAT2 in the alpha interferon signaling pathway, Mol. Cell. Biol., 15, 1312, 10.1128/MCB.15.3.1312 Licht, 2014, Caspase-3 and caspase-6 cleave STAT1 in leukemic cells, Oncotarget, 5, 2305, 10.18632/oncotarget.1911 Platanitis, 2019, A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription, Nat. Commun., 10, 2921, 10.1038/s41467-019-10970-y Urin, 2019, CRISPR/Cas9-based Knockout Strategy Elucidates Components Essential for Type 1 Interferon Signaling in Human HeLa Cells, J. Mol. Biol., 431, 3324, 10.1016/j.jmb.2019.06.007 Friedrich, 2017, Steering of carcinoma progression by the YIN/YANG interaction of STAT1/STAT3, Biosci. Trends, 11, 1, 10.5582/bst.2016.01250 Göder, 2020, Impact of the STAT1 N-terminal domain for fibrosarcoma cell responses to ɣ-irradiation, Exp. Results, 1, 10.1017/exp.2020.25 Mo, 2008, Nuclear beta-arrestin1 functions as a scaffold for the dephosphorylation of STAT1 and moderates the antiviral activity of IFN-gamma, Mol. Cell, 31, 695, 10.1016/j.molcel.2008.06.017 Suryawanshi, 2021, Dysregulation of Cell Signaling by SARS-CoV-2, Trends Microbiol., 29, 224, 10.1016/j.tim.2020.12.007 Mu, 2020, SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2, Cell Discov., 6, 65, 10.1038/s41421-020-00208-3 Xia, 2020, Evasion of Type I Interferon by SARS-CoV-2, Cell Rep., 33, 10.1016/j.celrep.2020.108234 Miorin, 2020, SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling, PNAS, 117, 28344, 10.1073/pnas.2016650117 Matsuyama, 2020, An aberrant STAT pathway is central to COVID-19, Cell Death Differ., 27, 3209, 10.1038/s41418-020-00633-7 Li, 2020, An integrative analysis identifying transcriptional features and key genes involved in COVID-19, Epigenomics, 12, 1969, 10.2217/epi-2020-0168 de Araujo, 2019, Structural Implications of STAT3 and STAT5 SH2 Domain Mutations, Cancers, 11, 10.3390/cancers11111757 Ahmed, 2020, A Network-Based Analysis Reveals the Mechanism Underlying Vitamin D in Suppressing Cytokine Storm and Virus in SARS-CoV-2 Infection, Front. Immunol., 11, 10.3389/fimmu.2020.590459 Karki, 2021, Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes, Cell, 184, 149, 10.1016/j.cell.2020.11.025 Boudewijns, 2020, STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters, Nat. Commun., 11, 5838, 10.1038/s41467-020-19684-y